Company: MGLD
Filing Date: 2025-01-24
Form Type: 424B5
Source: 0001493152-25-003567
Chunk: 27

Company: Marygold Companies, Inc.
Filing Date: 2025-01-24
Form: 424B5
Chunk 27
---
 or part of this option, they will purchase shares covered by the option at the initial public offering price that appears on the cover page of this prospectus supplement, less the underwriting discount. If this option is exercised in full, the total proceeds to us will be $__________, before deduction of underwriting discounts and expenses and other offering expenses. The underwriters have severally agreed that, to the extent the over-allotment option is exercised, they will each purchase a number of additional shares proportionate to the underwriter’s initial amount reflected in the foregoing table. To the extent the option is exercised and the conditions of the underwriting agreement are satisfied, we will be obligated to sell to the underwriters, and the underwriters will be obligated to purchase, these additional securities.

Discounts and Commissions

The following table shows the public offering price, underwriting discounts and proceeds, before expenses, to us. The information assumes either no exercise or full exercise by the underwriters of their over-allotment option.

|                                  |     | Per share |     | Total Without Overallotment Option |     | Total With           
 Overallotment Option |
| Public offering price            |     |           |     |                                    |     |                      |
| Underwriting discount (8%)       |     |           |     |                                    |     |                      |
| Proceeds, before expenses, to us |     |           |     |                                    |     |                      |

| S-21 |

We estimate that the expenses payable by us in connection with this offering, other than the underwriting discounts and commission referred to above, will be approximately $_______. Also, we have agreed to reimburse the underwriter for certain reasonable and documented expenses, and other out-of-pocket expenses, including the reasonable documented expenses of its legal counsel not to exceed $50,000.

Right of First Refusal

Pursuant to the terms of an engagement letter we entered into with Maxim, dated December 2, 2024, we have agreed that, upon the closing of an offering of our securities and assuming the receipt of gross proceeds by us of not less than $2,000,000 or more from such an offering, for a period from such closing until and including ____________, 202_, Maxim will have a right of first refusal to act as sole managing underwriter and sole book runner, sole placement agent, or sole sales agent, for any and all future registered offerings or private placements of our equity, equity-linked or debt securities for which we retain the service